According to Lexaria Bioscience latest financial reports the total debt is $136.17K, an increase of 1739.93% to 2022. At the end of 2022 company had $7.40K total debt. This figure represents the debts and financial obligations that Lexaria Bioscience combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $136.17K | 1739.93% |
2022 | $7.40K | -85.19% |
2021 | $49.99K | -58.36% |
2020 | $120.06K | - |